Amgen's Elliott Levy On Adaptive Design And Real-World Evidence Strategies

Levy, SVP of global development, notes that two years after launching an in-house Center for Design and Analysis, Amgen considers adaptive designs for most new studies and more than half include adaptive elements.

Elliott Levy from Amgen — Amgen SVP, Global Development, Elliott Levy • Source: Amgen Inc.

Amgen Inc.'s Elliott Levy, senior vice president of global development, notes that the company is focused on innovation in terms of both the molecules in its research and development pipeline and the R&D processes it employs to take novel therapies from preclinical studies through regulatory approval.

The company also has streamlined operational costs in anticipation of multiple blockbuster products facing generic and biosimilar competition with the...